PURE Bioscience, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2026
Total Assets: $1.2M
Liabilities Breakdown FY2026
Total Liabilities: $7.6M
Asset Breakdown
Total Assets: $1.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $569.0K | 47.7% |
| Accounts Receivable | $334.0K | 28.0% |
| Inventory | $193.0K | 16.2% |
| Property, Plant & Equipment | $8.0K | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $89.0K | 7.5% |
Liabilities Breakdown
Total Liabilities: $7.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $820.0K | 10.8% |
| Long-Term Debt | $6.6M | 87.0% |
| Other Liabilities | $170.0K | 2.2% |